Aspect | Details |
---|---|
Analytical method | Markov state transition model incorporating a decision tree |
Software used | Microsoft Excel 2010 |
Model perspective | UK NHS |
Time horizon | 1Â year |
Cycle length | 4Â weeks |
Patient population | Men with LUTS/BPH who have moderate-to-severe storage symptoms (≥8 micturitions/day and ≥2 urgency episodes/day*) and voiding symptoms |
Treatments | Once-daily FDC tablet of solifenacin 6Â mg plus TOCAS 0.4Â mg |
Tolterodine ER 4Â mg plus tamsulosin 0.4Â mg daily, given concomitantly | |
Outcomes | Total treatment costs |
Quality adjusted life years | |
Incremental cost-effectiveness ratio |